Establishment Labs Extends NuSil Supply Agreement Through 2031

• Establishment Labs signed a supply agreement amendment with NuSil Technology through wholly owned subsidiary ELSA on October 14, 2026.
• The amendment extends the initial term from December 31, 2026, to December 31, 2031, effective January 1, 2027.
• The agreement covers NuSil's manufacture and sale of medical-grade silicone for specified ELSA products.
• Up to five automatic one-year renewals apply unless either party gives written notice by December 31 of the year before expiration.
• Revised provisions cover payment and pricing, business continuity and intellectual property.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Establishment Labs Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-115928), on October 15, 2026, and is solely responsible for the information contained therein.